Evidence map›Paper›PMID 34919665›Full record

ArticleRheumatology (Oxford, England)2022

Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study.

Giuseppe A Ramirez, Marco Lanzillotta, Mikael Ebbo, Andreu Fernandez-Codina, Gaia Mancuso, Olimpia Orozco-Galvez, Lorenzo Dagna, Nicolas Schleinitz, Fernando Martínez-Valle, Emma L Culver and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Rheumatology (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giuseppe A RamirezUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele.ORCID 0000-0002-2889-366X
Marco LanzillottaUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele.
Mikael EbboInternal Medicine Department, Hôpital de la Timone, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.
Andreu Fernandez-CodinaGeneral Internal Medicine Division, Windsor Regional Hospital, Windsor.
Gaia MancusoUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele.
Olimpia Orozco-GalvezAutoimmune Diseases Research Lab, Universitat Autònoma de Barcelona.
Lorenzo DagnaUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele.
Nicolas SchleinitzInternal Medicine Department, Hôpital de la Timone, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.
Fernando Martínez-ValleAutoimmune Diseases Research Lab, Universitat Autònoma de Barcelona.
Emma L CulverTranslational Gastroenterology Unit, Oxford University Hospitals NHS Foundation Trust.
Emanuel Della-TorreUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autoimmune DiseasesCOVID-19Immunoglobulin G4-Related DiseaseHumansImmunoglobulin GRetrospective StudiesImmunoglobulin G

Identifiers

PMID34919665
PMCPMC9383139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.